Thomson Reuters Intends to Purchase up to 3 Million Shares Through Private Agreements

Purchases will be part of previously announced buyback program 

NEW YORK, March 18, 2016 /CNW/ -- Thomson Reuters (NYSE / TSX: TRI), the world's leading source of intelligent information for businesses and professionals, today announced that it intends to purchase up to 3 million of its common shares through private agreements with an armʹs-length third-party seller. Any shares purchased under these agreements will count towards the company's existing normal course issuer bid (NCIB), which allows it to buy back up to 39.2 million common shares between May 28, 2015 and May 27, 2016. The Ontario Securities Commission (OSC) has issued an issuer bid exemption order permitting the company to make such private agreement purchases.

These private agreement purchases are part of the company's plan announced in February 2016 to purchase up to an additional US$1.5 billion of its common shares.

The price that Thomson Reuters will pay for its common shares through private agreements will be at a discount to the prevailing market price on the Toronto Stock Exchange (TSX) at the time of purchase, may be made in one or more trades over time, and must otherwise comply with the terms of the OSC's order. Decisions regarding any future repurchases, including through private agreements, will depend on the timing for the sale of the company's Intellectual Property & Science business in addition to other factors, such as market conditions, share price and opportunities to invest capital for growth.

Information regarding each private purchase, including the number of common shares purchased and aggregate purchase price, will be available on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com following the completion of any such purchase.

To date, Thomson Reuters has purchased 10 million common shares under its NCIB pursuant to private agreements. The number of common shares which may be purchased under private agreements may not exceed 13,066,666, being one-third of the total number of common shares which may be purchased under the NCIB.

Thomson Reuters
Thomson Reuters is the world's leading source of news and information for professional markets. Our customers rely on us to deliver the intelligence, technology and expertise they need to find trusted answers. The business has operated in more than 100 countries for more than 100 years. Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges (symbol: TRI). For more information, visit www.thomsonreuters.com.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this news release are forward-looking, including the company's intention to purchase shares through private agreements. These forward-looking statements are based on certain assumptions and reflect our company's current expectations. As a result, forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. There is no assurance that the events described in any forward-looking statement will materialize. You are cautioned not to place undue reliance on forward-looking statements which reflect expectations only as of the date of this news release. Except as may be required by applicable law, Thomson Reuters disclaims any obligation to update or revise any forward-looking statements.

CONTACTS


MEDIA

INVESTORS



David Crundwell

Frank J. Golden

Senior Vice President, Corporate Affairs

Senior Vice President, Investor Relations

+1 646 223 5285

+1 646 223 5288

david.crundwell@tr.com

frank.golden@tr.com

 

Logo - http://photos.prnewswire.com/prnh/20130208/MM57185LOGO

SOURCE Thomson Reuters


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890